Enzo Biochem, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 17   

Articles published

ENZ 5.15 -0.03 (-0.58%)
price chart
Enzo Biochem Inc. (ENZ) Drops 5.7% on September 23
Enzo Biochem Inc. (ENZ) was one of the Russell 2000's biggest losers for September 23 as the stock slid 5.7% to $4.96, a loss of $0.30 per share.
Global Uveitis Market 2018 Forecasts & H2 2014 Therapeutic Pipeline Review in ...
Companies profiled in Global Uveitis Market 2014-2018 research report include Abbvie Inc., Alcon Laboratories Inc., Allergan Inc., Bausch & Lomb Inc., Artielle ImmunoTherapeutics Inc., Enzo Biochem Inc., Hanall Pharmaceutical Co. Ltd., Lux Biosciences Inc.
Related articles »  
Hot Stocks: Infinera Corporation (NASDAQ:INFN), American Realty Capital ...
American Realty Capital Properties, Inc. (NASDAQ:ARCP) monthly performance stands at -6.74% while its year to date performance is 0.75%.
Related articles »  
Enzo Pays $3.5M To End FCA Medicare Billing Suit
Law360, New York (September 25, 2014, 1:24 PM ET) -- Enzo Biochem Inc. has agreed to pay $3.5 million to settle state and federal False Claims Act allegations that the life sciences company sought to unlawfully increase Medicare and Medicaid profits by ...
Related articles »  
ContraFect Corporation Expands Senior Management Team
Prior to MSKCC, she was General Counsel at Enzo Biochem, Inc. (Enzo), a publicly-traded biotechnology company, from 2003 to 2012.
ContraFect hires Bogdanos as general counsel  Westfair Online
Related articles »  
Hot News: Cisco Systems, Inc. (NASDAQ:CSCO), Citigroup Inc. (NYSE:C ...
... Inc. and Rocky Holding, Inc. TriQuint Semiconductor, Inc. (NASDAQ:TQNT) has 0.30% insider ownership while its institutional ownership stands at 88.40%.
Indefiniteness After The Supreme Court Nautilus Decision � A Very �Delicate ...
AOL, Inc., Appeal no. 2013-1282, -1283, -1284, -1285 (Fed. Cir. Sept. 10, 2014), the appealed indefiniteness finding by the district court was affirmed by the Fed.
Related articles »  
Global NASH market is expected to reach $1.6 bn by 2020, says Allied Market ...
... and are collaborating with private research and academic institutes to conduct clinical trials. Key companies profiled in the report are: Genfit, Gilead Science, Novo Nordisk, Intercepts Pharmaceuticals, Enzo Biochem, Inc. and Raptor Pharmaceutical ...
IDEXX Laboratories Inc.: IDEXX Laboratories announces agreement to utilize ...
IDEXX Laboratories, Inc. (NASDAQ: IDEXX) announced today that it has entered into an agreement with Royal Philips (NYSE: PHG, AEX: PHIA), under which the company will use the Philips Digital Pathology Solution VET in IDEXX Reference Laboratories to ...